glp 1 patents Ozempic's patent problem: how Novo Nordisk lost control of a blockbuster drug. π Demand for GLP-1 weight-loss drugs has exploded, turning Ozempic into a $40bn+ revenue engine for Novo Nordisk. But, despite Novo, Lilly Patent Moves Keep
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Sep 29 - Oct 4


























